On October 12, 2020, WCG announced the formal unification of their five industry-leading IRBs – Western IRB (WIRB), Copernicus Group IRB (CGIRB), Midlands IRB (MLIRB), New England IRB (NEIRB), and Aspire IRB – into the single WCG IRB brand.
Since 2012, the organization has successfully assembled and integrated a powerful array of premiere IRBs, now synthesized into a single, industry-leading world-class IRB. WCG clients will experience a singular, unified process, fee schedule, and revolutionary submission platform that will not only elevate their user experience but also continue to deliver gold standard service always with the highest regard to ethics and integrity.
“WCG IRB now represents the most powerful single IRB in the world – with hundreds of thousands of users among sponsors, CROs, and institutions who rely on the global industry leader to set the standard for quality, efficiency, and timeliness in this critical step of the clinical trial process,” said Don Deieso, PhD, WCG CEO. “It’s just one more example of our commitment to leading the way for this industry and continuing to enable clinical research in a positive way.”
“We’ve been acting operating internally as a single IRB for years,” says Dawn Flitcraft, head of WCG’s Ethical Review Division. “This final step in the unification of our IRBs is the natural move toward what our clients have told us they need and want. WCG clients love the teams they work with – and they love the simplicity of the single IRB. Under the WCG IRB banner, they get the best of all worlds – they continue to work with the teams they know and trust, who have set the standard for our industry for decades – and those teams are now connected seamlessly for a more powerful, unified experience for our clients and partners.”